To further support its momentum in the eClinical market, Levin will join as the company’s first Chief Marketing Officer.
Reno, NV, September 1, 2022 — Crucial Data Solutions (CDS), a provider of innovative low-code/no-code technologies to advance clinical research, announced today that established industry executive David Levin has joined as Chief Marketing Officer. In this newly created role, David will lead go-to-market strategies and programs that contribute to the company’s continued growth.
“We’re proud of the growth we’ve experienced over the past several years which allows us to invest in this newly created role. We’re even more excited that we were able to attract an industry veteran of David’s caliber with a proven successful track record,” said Jeff Rogers, President of CDS. “His knowledge of clinical trials and experience in the healthcare sector will be great assets to help us advance our growth and position the company as one of the industry’s first integrated platforms for both traditional and decentralized trials (DCTs).”
Levin said, “I’m thrilled to join Crucial Data Solutions and excited to work with the entire team. As a mission-driven organization, we’re working hard to provide clinical research professionals with the technology they need to improve the lives of patients and expand access to critical new medical products and therapeutics.”
As a two-time CEO and executive at multiple startups, David Levin has developed a strong track record over his 25+ years of experience as a leader in building digital health companies. Prior to joining CDS, Levin was CEO at RelyMD, a telemedicine startup that was acquired earlier this year, where he led the company’s mission to make patients and their communities healthier. Previously, he spent 20 years building Bivarus, Clinipace Worldwide, and MercuryMD into successful companies – leading to three successful exits.
About Crucial Data Solutions
Founded in 2010, Crucial Data Solutions (CDS) provides the most innovative low-code/no-code data and clinical trial management technology on the market today. TrialKit, our cloud-based platform available via both a web and native mobile app, enables end-to-end clinical trial management for medical device, diagnostics, digital therapeutics, and biotechnology companies of all sizes. Design and deploy validated studies in days not weeks using our intuitive study builder that requires no programming. Over 10,000 global users have leveraged the flexibility of TrialKit to deploy over 7,000 studies across all phases of development, including Verily (a subsidiary of Alphabet), ICON GPHS, FUEL Studios, Catalyst Clinical Research, SISCAPA Assay Technologies, CDx Diagnostics, and Optinose, and many more. Learn more at https://www.crucialdatasolutions.com/
Director of Marketing
Crucial Data Solutions